Regulatory News
Thursday, June 23, 2016
UPDATE 2- U.S. spurns AstraZeneca's nasal spray flu vaccine as ineffective
LONDON/CHICAGO, June 23 (Reuters) - U.S. health officials
have advised doctors not to use AstraZeneca's FluMist in
the upcoming flu season based on three years of U.S. data
showing that the nasal...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment